Ciatto S, Rosselli Del Turco M, Ambrogetti D, Bravetti P, Catarzi S, Morrone D, Cariaggi M P
Research Center for Preventive Oncology, Florence, Italy.
Acta Radiol. 1997 Sep;38(5):815-20. doi: 10.1080/02841859709172416.
To evaluate the contribution of guided fine-needle aspiration cytology in reducing unnecessary biopsies of benign solid nonpalpable breast lesions with low suspicion of malignancy at mammography.
An evaluation was made of a consecutive series of 2444 solid nonpalpable breast lesions detected by mammography and undergoing guided (sonography or stereotaxy) fine-needle aspiration cytology. Surgical biopsy was made in the presence of strong suspicion of malignancy at mammography and/or of abnormal cytology.
The sensitivity was 96.7% and the specificity 77.7% (average follow-up 2.77 years). False-negative/inadequate cytology associated with low suspicion of malignancy at mammography resulted in a diagnostic delay in 27 cancer cases (invasive 20, intraductal 7). On the other hand, cytology led to surgical biopsy in 53 cancer cases which might not otherwise have been biopsied because of low radiological suspicion of cancer. Surgical biopsy of all cases, to avoid diagnostic delays, would have increased the benign biopsy rate by a factor of 4.5, with a rise in the benign: malignant biopsy ratio from 0.44:1 to 1.93:1.
Stereotaxy- or ultrasound-guided fine-needle aspiration cytology of nonpalpable mammographic abnormalities can achieve a sharp reduction in unnecessary benign biopsies in cases of low suspicion of malignancy at mammography.
评估在乳腺钼靶检查中对恶性可能性低的不可触及的乳腺实性良性病变进行超声引导下细针穿刺活检,以减少不必要活检的作用。
对连续2444例通过乳腺钼靶检查发现并接受超声引导(超声或立体定位)细针穿刺活检的不可触及的乳腺实性病变进行评估。在乳腺钼靶检查高度怀疑恶性和/或细胞学异常时进行手术活检。
敏感性为96.7%,特异性为77.7%(平均随访2.77年)。乳腺钼靶检查恶性可能性低且细胞学检查假阴性/不充分导致27例癌症诊断延迟(浸润性20例,导管内7例)。另一方面,细胞学检查导致53例癌症患者接受手术活检,否则因放射学检查对癌症怀疑度低可能不会进行活检。为避免诊断延迟对所有病例进行手术活检,会使良性活检率提高4.5倍,良性与恶性活检比例从0.44:1升至1.93:1。
对于乳腺钼靶检查发现的不可触及异常,立体定位或超声引导下细针穿刺活检可在乳腺钼靶检查对恶性可能性低的病例中大幅减少不必要的良性活检。